Finally, Chang, P et al. used MRI data from 259 patients with low or high grade gliomas from The Cancer Imaging Archive (TCIA) to train a CNN to predict IDH mutation, 1p/19q codeletion, and MGMT promoter methylation status simultaneously and using an automated segmentation tool (Chang et al., 2018). This evidence concerns the gene MGMT and central nervous system cancer.